Group 1: Company Overview - Weike Technology specializes in precision injection mold research, design, manufacturing, and sales, expanding into injection parts and health products, becoming a "mold-plastic integrated" large-scale production enterprise [2][3] - The company has established overseas production bases in Germany, Malaysia, Mexico, the USA, Singapore, and Vietnam since 2018, enhancing its global operational layout [2][3] - Weike has over 500 patents, including 27 authorized invention patents, and has been recognized as a key enterprise in precision injection molds and a national-level specialized "little giant" [3] Group 2: Financial Performance and Market Strategy - The company's export ratio is approximately 40%, but it is estimated to be over 60% when accounting for indirect exports [3] - Weike aims for a 20% growth in 2025, focusing on the automotive sector and plans to expand from secondary to primary supplier status [4] - The company has a gross margin higher than competitors due to technological leadership, customized small-batch production, and high-quality clients [4] Group 3: Challenges and Responses - The company is prepared for potential tariff increases due to the U.S. elections by leveraging its overseas production bases to support local deliveries [3] - Current overseas production capacity is relatively small, accounting for about 10%, as domestic production remains more cost-effective [3] - The company is exploring mergers and acquisitions to enhance its core competitiveness, with no geographical restrictions on potential targets [4] Group 4: Market Perception and Value Management - The company's market value is perceived as undervalued due to low market attention and small size, which diminishes its appeal to institutional investors [4][5] - Future strategies include improving market performance through mergers, dividends, equity incentives, and buybacks to enhance market recognition [5]
唯科科技(301196) - 2024年10月17日投资者关系活动记录表